Literature DB >> 17666945

Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia.

Sebastian N Stehr1, Lilla Knels, Christian Weissflog, Johannes Schober, Dirk Haufe, Amelie Lupp, Thea Koch, Axel R Heller.   

Abstract

Immunological interventions in endotoxemia and sepsis have been tested in experimental and clinical studies. Our group evaluated the effects of an immunoglobulin (Ig)M-enriched solution in an established model of Gram-negative bacteraemia. Ten New Zealand White rabbits (2-3 kg) were randomized to a treatment or control group. In both groups, LPS was infused at a rate of 40 mg kg(-1) h(-1). Immunoglobulin M-enriched solution (Pentaglobin; 2 mL kg(-1) h(-1)) was applied in the intervention group 15 min after beginning LPS infusion. 1 x 10(8) colony forming units of Escherichia coli were injected 30 min after LPS infusion was commenced. Baseline hemodynamic and respiratory parameters, blood E. coli concentration (30 min before and 1, 15, 30, 60, 90, 120, and 180 min after E. coli injection), polymorphonuclear neutrophil oxidative burst activity, and phagocytosis dead space (both 30 min before and 1, 15, 60, 120, and 180 min postinjection) were measured. Ex vivo phagocytosis activity was measured in a separate experiment and evaluated by electron microscopy. Diffuse alveolar damage (DAD) was measured. Organ colonization (kidney, lung, liver, spleen) was assessed in aseptic organ samples. Hemodynamic parameters did not differ between the two groups. Bacterial blood clearance was not influenced by application of IgM-enriched solution. Liver and spleen colonization was significantly reduced in the IgM group. Immunoglobulin M-enriched solution reduced in vitro residual phagocytosis capacity at 30, 90, and 180 min and improved respiratory burst at 180 min. Correspondingly, ex vivo phagocytosis activity as documented by electron microscopy was increased in the IgM group. The sum of all weighted DAD scores (except overdistension) was significantly better in the IgM group (23+/-5 vs. 30+/-8). Immunoglobulin M-enriched solution significantly improved six of seven DAD score parameters and reduced liver and spleen E. coli count. Residual phagocytosis capacity was significantly decreased in the IgM group, whereas burst activity was increased, pointing to an increased in vivo phagocytosis efficiency. Short-term IgM-enriched solution intervention had an especially beneficial effect on LPS-induced pulmonary histological changes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17666945     DOI: 10.1097/SHK.0b013e318067df15

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  12 in total

Review 1.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 2.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

3.  Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen.

Authors:  Stéphanie Longet; Cédric Vonarburg; Marius Lötscher; Sylvia Miescher; Adrian Zuercher; Blaise Corthésy
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

4.  Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.

Authors:  Ilaria Cavazzuti; Giulia Serafini; Stefano Busani; Laura Rinaldi; Emanuela Biagioni; Marta Buoncristiano; Massimo Girardis
Journal:  Intensive Care Med       Date:  2014-09-13       Impact factor: 17.440

5.  Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM.

Authors:  Edward S X Moh; Chi-Hung Lin; Morten Thaysen-Andersen; Nicolle H Packer
Journal:  J Am Soc Mass Spectrom       Date:  2016-04-01       Impact factor: 3.109

6.  Role of immunoglobulins in neonatal sepsis.

Authors:  L Capasso; Ac Borrelli; J Cerullo; R Pisanti; C Figliuolo; F Izzo; M Paccone; T Ferrara; S Lama; F Raimondi
Journal:  Transl Med UniSa       Date:  2014-12-19

7.  Effects of intravenous immunoglobulin therapy on behavior deficits and functions in sepsis model.

Authors:  Perihan Ergin Ozcan; Evren Senturk; Gunseli Orhun; Salih Gumru; Nadir Arican; Nurcan Orhan; Canan Ugur Yılmaz; Mehmet Kaya; Feyza Aricioglu; Figen Esen
Journal:  Ann Intensive Care       Date:  2015-07-31       Impact factor: 6.925

8.  Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?

Authors:  Letizia Capasso; Angela Carla Borrelli; Claudia Parrella; Silvia Lama; Teresa Ferrara; Clara Coppola; Maria Rosaria Catania; Vita Dora Iula; Francesco Raimondi
Journal:  Ital J Pediatr       Date:  2013-10-07       Impact factor: 2.638

9.  IgM-enriched solution BT086 improves host defense capacity and energy store preservation in a rabbit model of endotoxemia.

Authors:  S Shmygalev; M Damm; L Knels; A Strassburg; K Wünsche; R Dumke; S N Stehr; T Koch; A R Heller
Journal:  Acta Anaesthesiol Scand       Date:  2015-11-11       Impact factor: 2.105

Review 10.  Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.